In this series of briefs, we review the scope of Kaiser Permanente Research on a selection of high priority topics. We describe the contributions of Kaiser Permanente research to understanding risk, improving patient outcomes, and translating research into policy and practice, and profile some exemplar research publications in each topic.
One in 8 American women will develop breast disease during their lifetimes. Breast cancer accounts for about 41,000 deaths in the US every year. Since 2007, Kaiser Permanente scientists have published nearly 500 articles related to risk, prevention, diagnosis, treatment, and post-treatment monitoring.
Our research scientists have used our rich, longitudinal data to advance knowledge about cardiovascular disease and improve practice and patient outcomes. We have published more than 1,200 articles on this topic since 2007, which together have been cited nearly 75,000 times.
Colorectal cancer is the second leading cause of cancer death in the United States. Our research has estimated that more than half of these deaths are due to non-screening. We have contributed substantially to the evidence base on strategies to increase screening, and many other topics of related research.
Diabetes is an active area of study for Kaiser Permanente Research. We have published more than 840 articles related to this topic over the past decade.
Kaiser Permanente is among the largest providers of HIV care in the U.S. Our research has informed policy and practice and helped people live longer, healthier lives.
Mental health is an essential part of total wellbeing. With 600 publications since 2007, our research on this topic has made important contributions to understanding risk and improving patient outcomes.
These neurobiological disorders involve a complex interplay between genetics and environment and are an active area of study for Kaiser Permanente. Our articles published since 2007 have been cited more than 9,000 times.
Kaiser Permanente scientists who study vaccination have published findings that have been cited more than 50 times in recent guidelines and consensus statements. Our research has directly influenced national vaccines policies.